Pharmaprocess
Pharmaprocess, a leading name in the pharmaceutical and biotechnology sectors, is headquartered in Italy and operates extensively across Europe. Founded in 2005, the company has established itself as a key player in the design and manufacturing of innovative processing equipment for the pharmaceutical industry. Specialising in high-quality solutions for aseptic processing, Pharmaprocess offers unique products that enhance efficiency and compliance in drug production. Their commitment to cutting-edge technology and customer-centric service has earned them a strong market position, recognised for their contributions to improving pharmaceutical manufacturing processes. With a focus on sustainability and regulatory adherence, Pharmaprocess continues to set benchmarks in the industry, driving advancements that benefit both clients and patients alike.
DitchCarbon Score
How does Pharmaprocess's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaprocess's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaprocess's reported carbon emissions
Pharmaprocess, headquartered in Italy, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Pharmaprocess has not outlined any specific reduction targets or commitments to climate initiatives. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon reduction, Pharmaprocess may benefit from establishing clear climate commitments and measurable targets to align with global standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaprocess is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
